期刊
RADIOLOGIA MEDICA
卷 126, 期 3, 页码 356-364出版社
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s11547-020-01261-4
关键词
Computed Tomography Angiography; Coronary Vessels; Magnetic Resonance Imaging; Adrenergic beta-Antagonists; Ivabradine; Anti-Anxiety Agents; Adenosine; Dobutamine; Atropine; Dipyridamole; Regadenoson; Contraindications
The increasing number of noninvasive cardiac imaging examinations requires radiologists to acquire more knowledge in drug management during CT coronary angiography and cardiac MR to improve image quality and assessment of the coronary arteries. This review aims to provide an overview of different classes of drugs that can be used in CTCA and CMR, including their indications, contraindications, efficacy, mechanism of action, metabolism, safety, and potential side effects or complications.
The progressive increase in numbers of noninvasive cardiac imaging examinations broadens the spectrum of knowledge radiologists are expected to acquire in the management of drugs during CT coronary angiography (CTCA) and cardiac MR (CMR) to improve image quality for optimal visualization and assessment of the coronary arteries and adequate MR functional analysis. Aim of this review is to provide an overview on different class of drugs (nitrate, beta-blockers, ivabradine, anxiolytic, adenosine, dobutamine, atropine, dipyridamole and regadenoson) that can be used in CTCA and CMR, illustrating their main indications, contraindications, efficacy, mechanism of action, metabolism, safety, side effects or complications, and providing advices in their use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据